How rapid diagnostics can help curb antimicrobial resistance
Having reliable diagnostics at the point of care supports earlier detection of illnesses or other emerging threats, therefore reinforcing national response capacity.
Innovation and collaboration are the future of Canada’s public health care
When done well, public-private partnerships don’t weaken our public system, they make it stronger, more responsive, and more sustainable for the next generation.
Canada must step up to meet the challenge of dementia
Canada needs a national dementia co-ordinating body to guide policy implementation, set benchmarks for success, and manage data to evaluate progress.
Less focus on COVID-19 expected to lead to $650-million spending cuts for PHAC by 2027-2028
Overall spending, including internal services, could drop by nearly $650-million, from approximately $1.83-billion in 2025-26 to $1.18-billion in 2027-28. Expiring funding for some mental health and diabetes initiatives are also contributing to fewer dollars, states the agency’s 2025-26 plan.
A strong economy depends on a strong social sector
We must invest in the social infrastructure that supports essential community services that return value to the economy and to communities.
What the early pharmacare rollout is teaching us—and why governments must listen
Canada must move beyond assuming that a single-payer model alone can solve systemic gaps in access, and design a truly universal system that works alongside private plans.
Carney: don’t gamble with Canada’s food security
Inspectors, scientists, technicians, and support staff ensure the food we eat is safe, the farms we rely on are supported, and the agricultural economy remains strong—but they can’t do more with less.
Speed up bureaucrats’ return to work by making athletic therapy more accessible
Adding this therapy to public sector benefit plans could shorten recovery times, reduce long-term absences and save public funds.
Trump’s tariffs are a collision with economic reality
An often-overlooked aspect of protective tariffs is that returning manufacturing to the U.S. will inevitably raise the cost of consumer goods and burden domestic manufacturers.
Still no strategy: the federal silence on women’s health
A narrow lens on gynecology, pregnancy, and fertility has created a profound policy failure, contributing to stagnating progress in women’s health research, care, and infrastructure.
